SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.06400.0%Nov 7 3:22 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Howard Williams1/13/2014 8:06:57 AM
   of 13111
 
Provectus News BioCentury covers news of Provectus Type C Meeting With FDA
Monday January 13, 2014


The Week in Review - Company News section of the January 6th edition of BioCentury covered news of Provectus' December 16th Type C meeting with the FDA and that the FDA should issue meeting minutes by January 15th.

With permission of the publisher, a reprint of the BioCentury article is available from the Provectus website at www.pvct.com//news/BioCentury-PVCT-01-06-2014.pdf.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext